April is National Testicular Cancer Awareness Month, and at SCRI Oncology Partners, we recognize it is a crucial time to spotlight the importance of awareness and research in the fight against this disease. Testicular cancer predominantly impacts young and middle-aged...
Benjamin Garmezy
The Lancet
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Oncology and Therapy
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast
Cancer Research Community
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Oncology and Therapy
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast
JCO Precision Oncology
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers